Annual Current Liabilities
$2.88 M
+$1.01 M+54.37%
31 March 2024
Summary:
Portage Biotech annual total current liabilities is currently $2.88 million, with the most recent change of +$1.01 million (+54.37%) on 31 March 2024. During the last 3 years, it has fallen by -$329.00 thousand (-10.26%). PRTG annual current liabilities is now -17.86% below its all-time high of $3.51 million, reached on 31 March 2010.PRTG Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$873.00 K
-$2.13 M-70.95%
30 September 2024
Summary:
Portage Biotech quarterly total current liabilities is currently $873.00 thousand, with the most recent change of -$2.13 million (-70.95%) on 30 September 2024. Over the past year, it has dropped by -$1.83 million (-67.76%). PRTG quarterly current liabilities is now -93.20% below its all-time high of $12.83 million, reached on 31 December 2009.PRTG Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTG Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +54.4% | -67.8% |
| 3 y3 years | -10.3% | +37.3% |
| 5 y5 years | +60.5% | -44.4% |
PRTG Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -10.3% | +267.7% | -72.2% | +37.3% |
| 5 y | 5 years | -10.3% | +267.7% | -82.1% | +37.3% |
| alltime | all time | -17.9% | +6754.8% | -93.2% | +5288.9% |
Portage Biotech Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $873.00 K(-70.9%) |
| June 2024 | - | $3.00 M(+4.4%) |
| Mar 2024 | $2.88 M(+54.4%) | $2.88 M(+6.3%) |
| Dec 2023 | - | $2.71 M(-13.6%) |
| Sept 2023 | - | $3.14 M(+18.9%) |
| June 2023 | - | $2.64 M(+41.4%) |
| Mar 2023 | $1.86 M(+138.2%) | $1.86 M(-23.0%) |
| Dec 2022 | - | $2.42 M(+69.0%) |
| Sept 2022 | - | $1.43 M(-27.3%) |
| June 2022 | - | $1.97 M(+151.6%) |
| Mar 2022 | $783.00 K(-75.6%) | $783.00 K(+23.1%) |
| Dec 2021 | - | $636.00 K(-52.7%) |
| Sept 2021 | - | $1.34 M(-46.4%) |
| June 2021 | - | $2.51 M(-21.9%) |
| Mar 2021 | $3.21 M(+24.9%) | $3.21 M(+142.1%) |
| Dec 2020 | - | $1.32 M(-72.9%) |
| Sept 2020 | - | $4.89 M(+86.4%) |
| June 2020 | - | $2.62 M(+2.1%) |
| Mar 2020 | $2.57 M(+43.1%) | $2.57 M(+63.5%) |
| Dec 2019 | - | $1.57 M(-15.2%) |
| Sept 2019 | - | $1.85 M(-11.8%) |
| June 2019 | - | $2.10 M(+17.1%) |
| Mar 2019 | $1.79 M(+1088.1%) | $1.79 M(+891.2%) |
| Dec 2018 | - | $181.00 K(+129.1%) |
| Sept 2018 | - | $79.00 K(-18.6%) |
| June 2018 | - | $97.00 K(-35.8%) |
| Mar 2018 | $151.00 K(+38.5%) | $151.00 K(-92.9%) |
| Dec 2017 | - | $2.12 M(+1124.9%) |
| Sept 2017 | - | $173.00 K(+42.2%) |
| June 2017 | - | $121.70 K(+11.7%) |
| Mar 2017 | $109.00 K(-63.6%) | $109.00 K(-16.9%) |
| Dec 2016 | - | $131.20 K(+70.8%) |
| Sept 2016 | - | $76.80 K(-92.7%) |
| June 2016 | - | $1.05 M(+249.6%) |
| Mar 2016 | $299.70 K(-51.7%) | $299.70 K(+268.6%) |
| Dec 2015 | - | $81.30 K(-53.8%) |
| Sept 2015 | - | $175.90 K(-72.0%) |
| June 2015 | - | $628.00 K(+1.2%) |
| Mar 2015 | $620.60 K(+223.2%) | $620.60 K(-38.9%) |
| Dec 2014 | - | $1.02 M(+74.4%) |
| Sept 2014 | - | $582.90 K(+17.4%) |
| June 2014 | - | $496.40 K(+158.5%) |
| Mar 2014 | $192.00 K(-57.0%) | $192.00 K(+103.4%) |
| Dec 2013 | - | $94.40 K(-5.3%) |
| Sept 2013 | - | $99.70 K(-41.4%) |
| June 2013 | - | $170.10 K(-61.9%) |
| Mar 2013 | $446.90 K | $446.90 K(+257.2%) |
| Dec 2012 | - | $125.10 K(-61.8%) |
| Sept 2012 | - | $327.80 K(-74.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $1.30 M(-51.2%) |
| Mar 2012 | $2.66 M(+289.8%) | $2.66 M(+162.4%) |
| Dec 2011 | - | $1.01 M(+41.8%) |
| Sept 2011 | - | $715.40 K(+0.3%) |
| June 2011 | - | $713.40 K(+4.5%) |
| Mar 2011 | $682.80 K(-80.5%) | $682.80 K(-67.0%) |
| Dec 2010 | - | $2.07 M(+13.9%) |
| Sept 2010 | - | $1.82 M(+1.8%) |
| June 2010 | - | $1.78 M(-49.1%) |
| Mar 2010 | $3.51 M(+2811.3%) | $3.51 M(-72.7%) |
| Dec 2009 | - | $12.83 M(>+9900.0%) |
| Sept 2009 | - | $77.20 K(-54.6%) |
| June 2009 | - | $170.10 K(+41.3%) |
| Mar 2009 | $120.40 K(+110.1%) | $120.40 K(+38.7%) |
| Dec 2008 | - | $86.80 K(+150.1%) |
| Sept 2008 | - | $34.70 K(-36.6%) |
| June 2008 | - | $54.70 K(-4.5%) |
| Mar 2008 | $57.30 K(+36.4%) | $57.30 K(+34.5%) |
| Dec 2007 | - | $42.60 K(+7.6%) |
| Sept 2007 | - | $39.60 K(-36.9%) |
| June 2007 | - | $62.80 K(+49.5%) |
| Mar 2007 | $42.00 K(-70.3%) | $42.00 K(+159.3%) |
| Dec 2006 | - | $16.20 K(-64.7%) |
| Sept 2006 | - | $45.90 K(+10.1%) |
| June 2006 | - | $41.70 K(-70.5%) |
| Mar 2006 | $141.50 K(+37.6%) | $141.50 K(+52.2%) |
| Dec 2005 | - | $93.00 K(+116.3%) |
| Sept 2005 | - | $43.00 K(-39.0%) |
| June 2005 | - | $70.50 K(-31.4%) |
| Mar 2005 | $102.80 K(-84.4%) | $102.80 K(-40.7%) |
| Dec 2004 | - | $173.40 K(-26.2%) |
| Sept 2004 | - | $235.10 K(+49.7%) |
| June 2004 | - | $157.00 K(-76.2%) |
| Mar 2004 | $660.60 K(+182.5%) | $660.60 K(+19.9%) |
| Dec 2003 | - | $551.10 K(+19.4%) |
| Sept 2003 | - | $461.70 K(+71.8%) |
| June 2003 | - | $268.80 K(+15.0%) |
| Mar 2003 | $233.80 K(+84.8%) | $233.80 K(+11.5%) |
| Dec 2002 | - | $209.70 K(+11.8%) |
| Sept 2002 | - | $187.60 K(+24.9%) |
| June 2002 | - | $150.20 K(+18.7%) |
| Mar 2002 | $126.50 K(+33.7%) | $126.50 K(-4.0%) |
| Dec 2001 | - | $131.80 K(+81.8%) |
| Sept 2001 | - | $72.50 K(-9.7%) |
| June 2001 | - | $80.30 K(-15.1%) |
| Mar 2001 | $94.60 K(-37.6%) | $94.60 K(-27.3%) |
| Dec 2000 | - | $130.10 K |
| Mar 2000 | $151.70 K(+133.0%) | - |
| Mar 1999 | $65.10 K(-86.9%) | - |
| Mar 1998 | $496.70 K | - |
FAQ
- What is Portage Biotech annual total current liabilities?
- What is the all time high annual current liabilities for Portage Biotech?
- What is Portage Biotech annual current liabilities year-on-year change?
- What is Portage Biotech quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Portage Biotech?
- What is Portage Biotech quarterly current liabilities year-on-year change?
What is Portage Biotech annual total current liabilities?
The current annual current liabilities of PRTG is $2.88 M
What is the all time high annual current liabilities for Portage Biotech?
Portage Biotech all-time high annual total current liabilities is $3.51 M
What is Portage Biotech annual current liabilities year-on-year change?
Over the past year, PRTG annual total current liabilities has changed by +$1.01 M (+54.37%)
What is Portage Biotech quarterly total current liabilities?
The current quarterly current liabilities of PRTG is $873.00 K
What is the all time high quarterly current liabilities for Portage Biotech?
Portage Biotech all-time high quarterly total current liabilities is $12.83 M
What is Portage Biotech quarterly current liabilities year-on-year change?
Over the past year, PRTG quarterly total current liabilities has changed by -$1.83 M (-67.76%)